Insulin Delivery Devices 2017 Global Market Key Players –Eli Lily and Company (U.S.), Medtronic, Inc. (Ireland), Becton, Dickinson and Company (U.S.), Sanofi (France) – Analysis and Forecast to 2020

Insulin Delivery Devices Market 2017

Introduction
Diabetes is a chronic disease caused due to insufficient production or inappropriate use of insulin in the body. It is a collection of diseases characterized by elevated blood glucose level. It is mainly of two types namely, Type 1 and Type 2 diabetes. Type 1 is caused due to lack of insulin, whereas Type 2 diabetes is caused due to the futile use of insulin.
Globally, insulin delivery device is witnessing growth primarily due to increase in the prevalence of diabetes. The rise in the geriatric population, growing awareness of diabetes and technological advancement in the delivery device are also driving the growth of the market. In addition, risk factors for Type 2 diabetes and high blood pressure are increasing steadily with the rise in obesity. However, the high cost of insulin and the risks associated with delivery devices are inhibiting the growth of the market.
The global insulin delivery devices market is expected to reach USD 14.2 billion by 2020 at a CAGR of 6.9% during the forecast period.
On the basis of types, insulin delivery devices market has been segmented into insulin syringe, insulin pump, insulin pen, insulin jet injectors, and others. Insulin syringe segment has had the largest market share of global insulin delivery devices in 2016, registering $3.5 billion revenue or the year. The Insulin pumps segment is anticipated to grow at the highest CAGR of 7.5% during the forecast period.
On the basis of geography, the market has been subdivided into North America, Europe, Asia, and Rest of the World. North America commanded the largest market share of around 43% in 2015, while Asian region is expected to register the fastest growing CAGR of 7.3% during the forecast period.

Key Players
The leading market players in the global insulin delivery devices market include are Novo Nordisk A/S (Denmark), Eli Lily and Company (U.S.), Medtronic, Inc. (Ireland), Becton, Dickinson and Company (U.S.), Sanofi (France), and F. Hoffmann-La Roche. (Switzerland).

Study Objectives
• To provide insights about factors influencing and affecting the market growth
• To provide historical and forecast revenue of the regional markets and their key countries with respect to market segments
• To provide historical and forecast revenue of the market segmented on the basis of products, and applications
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

Request For Sample Report @ https://www.wiseguyreports.com/sample-request/869776-global-insulin-delivery-devices-market-estimation-forecast-2013-2020

Target Audience
• Medical Devices Manufacturers
• Medical Devices Distributors
• Pharmaceutical companies
• Hospitals & Clinics
• Service Suppliers
• Potential Investors
• Key executive (CEO and COO) and strategy growth manager

Key Findings
• North America dominated the global market, and was valued at USD 4.6 billion in 2016. It is expected to reach USD 6.0 billion by 2020
• Insulin pump will be the fastest growing application segment growing at a CAGR of 7.5% from 2016 to 2020
• Europe market was valued at USD 3.3 billion in 2016, and is expected to reach USD 4.4 billion by 2020.

The reports also cover country level analysis:
• North America
o US
o Canada

Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Europe
Asia
o China
o Japan
o India
o Rest of Asia
• Rest of the World (RoW)

Complete Report Details @ https://www.wiseguyreports.com/reports/869776-global-insulin-delivery-devices-market-estimation-forecast-2013-2020

Table of Contents

Chapter 1. Research Scope and Methodology 11
1.1 Market Definition 11
1.2 Market Breakdown by Type 11
1.3 Market Breakdown by Geography 11
1.4 Research Methodology and Sources 12

Chapter 2. Executive Summary 14
2.1 Key Findings 14
2.2 Research Summary 14

….

Chapter 8. Company Profiles 61
8.1 Medtronic, Inc. 61
8.1.1 Business overview 61
8.1.2 Products and services offerings 61
8.1.3 Recent developments 62
8.1.4 Key P&L metrics 62
8.2 F. Hoffmann-La Roche, Ltd. 63
8.2.1 Business overview 63
8.2.2 Products and services offerings 63
8.2.3 Recent developments 64
8.2.4 Key P&L metrics 64
8.3 Abbott Laboratories, Inc. 64
8.3.1 Business overview 65
8.3.2 Products and services offerings 65
8.3.3 Recent developments 65
8.3.4 Key P&L metrics 66
8.4 Novo Nordisk A/S 66
8.4.1 Business overview 66
8.4.2 Products and services offerings 66
8.4.3 Recent developments 67
8.4.4 Key P&L metrics 67
8.5 Eli Lilly and Company 67
8.5.1 Business overview 68
8.5.2 Products and services offerings 68
8.5.3 Recent developments 68
8.5.4 Key P&L metrics 68
8.6 Sanofi 69
8.6.1 Business overview 69
8.6.2 Products and services offerings 69
8.6.3 Recent developments 70
8.6.4 Key P&L metrics 70
8.7 Becton, Dickinson and Company 70
8.7.1 Business overview 70
8.7.2 Products and services offerings 71
8.7.3 Recent developments 71
8.7.4 Key P&L metrics 71
8.8 B. Braun Melsungen AG 72
8.8.1 Business overview 72
8.8.2 Products and services offerings 72
8.8.3 Recent developments 73
8.8.4 Key P&L metrics 73
8.9 Animas Corporation 73
8.9.1 Business overview 73
8.9.2 Product and services offerings 74
8.9.3 Recent developments 74
8.9.4 Key P&L metrics 74
8.10 Ypsomed Holdings AG 75
8.10.1 Business overview 75
8.10.2 Products and services offerings 75
8.10.3 Recent developments 75
8.10.4 Key P&L metrics 76
8.11 Insulet Corporation 76
8.11.1 Business overview 77
8.11.2 Product and services offerings 77
8.11.3 Recent developments 77
8.11.4 Key P&L metrics 78
Continued…….

For accessing accurate and deep understanding and to gain latest insights and key developments in the area of your interest, we also have a list of conferences in which you will be interested in, for more information, cordially check :

https://www.wiseguyreports.com/conferences

For updating knowledge or for thoroughly understanding various terminologies, we also have vast list of seminars for your reference, for more information cordially check :

https://www.wiseguyreports.com/seminars

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

ADDRESS:
WISE GUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune - 411028
Maharashtra, India

This release was published on openPR.